Makoto Nakao

Yatomi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Usefulness of White Blood Cell Differential-based Indices in Patients With Extensive-stage Small Cell Lung Cancer.

Usefulness of White Blood Cell Differential-based Indices in Patients With Extensive-stage Small Cell Lung Cancer.

Journal: Cancer diagnosis & prognosis
Published: October 05, 2025

Evaluation of prognostic factors using nutritional indicators in extensive-stage small cell lung cancer.

Evaluation of prognostic factors using nutritional indicators in extensive-stage small cell lung cancer.

Journal: Journal of rural medicine : JRM
Published: June 30, 2025

Albumin-based Liver Reserve Models as Prognostic Markers for Patients With Extensive-stage Small-cell Lung Cancer.

Albumin-based Liver Reserve Models as Prognostic Markers for Patients With Extensive-stage Small-cell Lung Cancer.

Journal: Anticancer research
Published: June 09, 2025

Lung cancer with diabetes mellitus and polymyalgia rheumatica during long?term nivolumab treatment: A case report.

Lung cancer with diabetes mellitus and polymyalgia rheumatica during long?term nivolumab treatment: A case report.

Journal: Experimental and therapeutic medicine
Published: December 22, 2024

Sarcomatoid pleural mesothelioma evaluated using diffusion-weighted whole-body imaging with background body signal suppression.

Sarcomatoid pleural mesothelioma evaluated using diffusion-weighted whole-body imaging with background body signal suppression.

Journal: Respiratory investigation
Published: November 11, 2024

Geriatric Nutritional Risk Index as Prognostic Marker for Elderly Patients With Small Cell Lung Cancer.

Geriatric Nutritional Risk Index as Prognostic Marker for Elderly Patients With Small Cell Lung Cancer.

Journal: Cancer diagnosis & prognosis
Published: March 19, 2024

Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer.

Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer.

Journal: Anticancer research
Published: December 28, 2023

Nineteen-Month Immunity to Adverse Radiation Effects Following 5-Fraction Re-radiosurgery With 43.6 Gy for Local Progression After Prior 3-Fraction Radiosurgery for Brain Metastasis From Pan-Negative Lung Adenocarcinoma.

Nineteen-Month Immunity to Adverse Radiation Effects Following 5-Fraction Re-radiosurgery With 43.6 Gy for Local Progression After Prior 3-Fraction Radiosurgery for Brain Metastasis From Pan-Negative Lung Adenocarcinoma.

Journal: Cureus
Published: October 02, 2023

Volumetric-Modulated Arc-Based Re-radiosurgery With Simultaneous Reduced-Dose Whole-Brain Irradiation for Local Failures Following Prior Radiosurgery of Brain Oligometastases From Small Cell Lung Cancer.

Volumetric-Modulated Arc-Based Re-radiosurgery With Simultaneous Reduced-Dose Whole-Brain Irradiation for Local Failures Following Prior Radiosurgery of Brain Oligometastases From Small Cell Lung Cancer.

Journal: Cureus
Published: August 31, 2023

Twenty-Month Regression Following Concurrent Conventional Whole-Brain Irradiation and Chemoimmunotherapy for ≥3.8 cm Cerebellar Metastasis From Small Cell Lung Cancer.

Twenty-Month Regression Following Concurrent Conventional Whole-Brain Irradiation and Chemoimmunotherapy for ≥3.8 cm Cerebellar Metastasis From Small Cell Lung Cancer.

Journal: Cureus
Published: August 19, 2023

Clinical activity of crizotinib in lung adenocarcinoma harboring a HLA_A‑ROS1 rearrangement: A case report.

Clinical activity of crizotinib in lung adenocarcinoma harboring a HLA_A‑ROS1 rearrangement: A case report.

Journal: Oncology letters
Published: July 13, 2023

Five-Year Sustained Complete Remission With Minimal Adverse Effects Following Radiosurgery for 2-cm Brain Metastasis With Deep Eloquent Location From Lung Adenocarcinoma Despite Low Marginal Dose and High 12 Gy Volume.

Five-Year Sustained Complete Remission With Minimal Adverse Effects Following Radiosurgery for 2-cm Brain Metastasis With Deep Eloquent Location From Lung Adenocarcinoma Despite Low Marginal Dose and High 12 Gy Volume.

Journal: Cureus
Published: March 25, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026